$415 Million is the total value of Sio Capital Management, LLC's 71 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 61.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDT | Sell | MEDTRONIC PLC | $9,395,000 | -21.5% | 96,464 | -26.6% | 2.26% | -29.9% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $8,285,000 | -26.3% | 526,059 | -31.4% | 2.00% | -34.2% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $6,264,000 | -26.0% | 754,759 | -11.4% | 1.51% | -34.0% |
| CVS | Sell | CVS HEALTH CORP | $6,198,000 | -68.7% | 113,738 | -69.0% | 1.49% | -72.0% |
| GMED | Sell | GLOBUS MEDICAL INCcl a | $4,350,000 | -56.6% | 102,827 | -49.3% | 1.05% | -61.2% |
| MOH | Sell | MOLINA HEALTHCARE INC | $4,294,000 | -32.7% | 30,000 | -33.2% | 1.04% | -39.9% |
| HROW | Sell | HARROW HEALTH INC | $4,099,000 | +52.1% | 471,114 | -12.9% | 0.99% | +35.7% |
| IDXX | Sell | IDEXX LABORATORIES INCput | $3,965,000 | +4.9% | 14,400 | -14.8% | 0.96% | -6.3% |
| STRO | Sell | SUTRO BIOPHARMA INC | $3,858,000 | -15.1% | 339,059 | -15.0% | 0.93% | -24.1% |
| MEIP | Sell | MEI PHARMA INC | $3,775,000 | -47.8% | 1,510,086 | -35.9% | 0.91% | -53.4% |
| SNN | Sell | SMITH & NEPHEW PLCspdn adr new | $3,313,000 | -25.1% | 76,102 | -31.0% | 0.80% | -33.1% |
| BNGO | Sell | BIONANO GENOMICS INC*w exp 08/21/2023 | $2,688,000 | -41.9% | 1,519,793 | -1.2% | 0.65% | -48.2% |
| EBS | Sell | EMERGENT BIOSOLUTIONS INC | $2,338,000 | -74.3% | 48,400 | -73.1% | 0.56% | -77.0% |
| LOGC | Sell | LOGICBIO THERAPEUTICS INC | $1,723,000 | +9.7% | 132,540 | -16.6% | 0.42% | -2.1% |
| VICL | Sell | VICAL INC | $1,130,000 | -41.7% | 1,329,657 | -17.7% | 0.27% | -48.1% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $523,000 | -13.3% | 20,310 | -52.1% | 0.13% | -22.7% |
| LXRX | Exit | LEXICON PHARMACEUTICALS INCput | $0 | – | -21,600 | -100.0% | -0.03% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -3,000 | -100.0% | -0.06% | – |
| MASI | Exit | MASIMO CORPput | $0 | – | -3,300 | -100.0% | -0.12% | – |
| RMED | Exit | RA MEDICAL SYSTEMS INC | $0 | – | -173,652 | -100.0% | -0.16% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -346,410 | -100.0% | -0.34% | – |
| IDXG | Exit | INTERPACE DIAGNOSTICS GROUP INC | $0 | – | -1,653,097 | -100.0% | -0.36% | – |
| GNFT | Exit | GENFIT SAads | $0 | – | -92,637 | -100.0% | -0.60% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INCput | $0 | – | -21,800 | -100.0% | -0.66% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -239,827 | -100.0% | -0.86% | – |
| PEN | Exit | PENUMBRA INCput | $0 | – | -24,000 | -100.0% | -0.95% | – |
| SYK | Exit | STRYKER CORPput | $0 | – | -19,200 | -100.0% | -1.02% | – |
| VAR | Exit | VARIAN MEDICAL SYSTEMS INCput | $0 | – | -27,600 | -100.0% | -1.06% | – |
| PETS | Exit | PETMED EXPRESS INC | $0 | – | -178,151 | -100.0% | -1.10% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -75,000 | -100.0% | -1.10% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -1,609,265 | -100.0% | -1.12% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -84,695 | -100.0% | -1.15% | – |
| ISRG | Exit | INTUITIVE SURGICAL INCput | $0 | – | -9,900 | -100.0% | -1.52% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -51,300 | -100.0% | -1.62% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -156,854 | -100.0% | -1.88% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -530,175 | -100.0% | -1.99% | – |
| NVO | Exit | NOVO NORDISK A/Sadr | $0 | – | -162,000 | -100.0% | -2.29% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCput | $0 | – | -50,800 | -100.0% | -2.31% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCput | $0 | – | -165,500 | -100.0% | -2.83% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -90,325 | -100.0% | -2.87% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -245,968 | -100.0% | -4.32% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -78,596 | -100.0% | -5.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.